The Global Ranitidine Market, by Strength (75 mg, 150 mg, and 300 mg), by Form (Tablets, Syrup, and Injection), by Route of Administration (Oral and Intravenous), by Application (Intestinal & Stomach Ulcers, Gastroesophageal Reflux Disease (GERD), Esophagitis, Zollinger-Ellison Syndrome, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), was valued US$ 412.4 Mn in 2017, and is projected to exhibit a CAGR of 1.8% over the forecast period (2018 - 2026) as highlighted in a new report published by Coherent Market Insights.
Key players in ranitidine market are engaged in gaining regulatory approvals for generic formulation of ranitidine. For instance, in August 2010, Aurobindo Pharma received U.S. Food and Drug Administration (FDA) approval to sell generic version of ranitidine syrup in the U.S. Aurobindo Pharma’s ranitidine syrup is the generic version of GlaxoSmithKline’s Zantac syrup.
In August 2018, Granules India Limited received U.S. FDA approval for Ranitidine HCL 150mg tablets and 150 mg Cool Mint (OTC). This product is bioequivalent to Sanofi-aventis’ 150 mg Zantac tablets.
Browse Market Data Tables and 25 Figures spread through 145 Pages and in-depth TOC on "Ranitidine Market, , by Strength (75 mg, 150 mg, and 300 mg), by Form (Tablets, Syrup, and Injection), by Route of Administration (Oral and Intravenous), by Application (Intestinal & Stomach Ulcers, Gastroesophageal Reflux Disease (GERD), Esophagitis, Zollinger-Ellison Syndrome, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies),- Global Forecast to 2026"
To know the latest trends and insights related to ranitidine market, click the link below:
Furthermore, growing strategic collaboration and joint venture by major players to launch new ranitidine-based products, is expected to drive growth of ranitidine market. For instance, in September 2013, Boehringer Ingelheim GmbH launched Captain Zantac, a new marketing campaign for Boehringer Ingelheim Consumer Health Care’s Zantac brand. Captain Zantac is Boehringer Ingelheim Consumer Health Care’s novel 360-degree brand equity campaign, which includes national television advertising and several other promotional campaign through print, online, and retail channels.
In May 2017, Strides Pharma Science Limited (Strides Shasun) and Vivimed Labs signed definitive agreement to set 50:50 joint venture to launch ranitidine tablet 150 mg in the U.S.
In February 2018, Strides Shasun launched Ranitidine Tablets USP, 150 mg in the U.S. market. Furthermore, in March 2018, company launched Ranitidine Tablets USP, 75 mg in the U.S. market. The new launch will strengthen Strides’ ranitidine portfolio in the U.S. ranitidine market.
Key takeaways of Ranitidine Market:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.